The effect of antibacterial peptide human β-defensin-2 on interleukin-18 secretion by keratinocytes
- 31 March 2005
- journal article
- other
- Published by Elsevier in Journal of Dermatological Science
- Vol. 37 (3) , 188-191
- https://doi.org/10.1016/j.jdermsci.2004.12.019
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Human β‐defensin‐2 functions as a chemotactic agent for tumour necrosis factor‐α‐treated human neutrophilsImmunology, 2004
- Persistent secretion of IL-18 in the skin contributes to IgE response in mice.International Immunology, 2003
- Increased secretion of IL-18in vitroby peripheral blood mononuclear cells of patients with bronchial asthma and atopic dermatitisClinical and Experimental Immunology, 2001
- Interleukin-18 Regulates Both Th1 and Th2 ResponsesAnnual Review of Immunology, 2001
- Evaluation of the effects of peptide antibiotics human β‐defensins‐1/‐2 and LL‐37 on histamine release and prostaglandin D2production from mast cellsEuropean Journal of Immunology, 2001
- Human keratinocytes constitutively produce but do not process interleukin-18British Journal of Dermatology, 2000
- Human Keratinocytes Constitutively Express Interleukin-18 and Secrete Biologically Active Interleukin-18 After Treatment with Pro-Inflammatory Mediators and DinitrochlorobenzeneJournal of Investigative Dermatology, 1999
- Caspase-1-Independent, Fas/Fas Ligand–Mediated IL-18 Secretion from Macrophages Causes Acute Liver Injury in MiceImmunity, 1999
- Epithelial Antimicrobial Peptides: Review and Significance for Oral ApplicationsCritical Reviews in Oral Biology & Medicine, 1998